Indications and Purposes
| 1 Indications And Usage Ofev Is A Kinase Inhibitor Indicated For: Treatment Of Idiopathic Pulmonary Fibrosis (Ipf). ( 1.1 ) Treatment Of Chronic Fibrosing Interstitial Lung Diseases (Ilds) With A Progressive Phenotype ( 1.2 ) Slowing The Rate Of Decline In Pulmonary Function In Patients With Systemic Sclerosis-Associated Interstitial Lung Disease (Ssc-Ild). ( 1.3 ) 1.1 Idiopathic Pulmonary Fibrosis Ofev Is Indicated For The Treatment Of Idiopathic Pulmonary Fibrosis (Ipf). 1.2 Chronic Fibrosing Interstitial Lung Diseases With A Progressive Phenotype Ofev Is Indicated For The Treatment Of Chronic Fibrosing Interstitial Lung Diseases (Ilds) With A Progressive Phenotype [See Clinical Studies (14.2) ] . 1.3 Systemic Sclerosis-Associated Interstitial Lung Disease Ofev Is Indicated To Slow The Rate Of Decline In Pulmonary Function In Patients With Systemic Sclerosis-Associated Interstitial Lung Disease (Ssc-Ild). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Nintedanib Esylate |
|
ZINC100014909 |